Updated network meta-analysis assessing the relative efficacy of 13 GLP-1 RA and SGLT2 inhibitor interventions on cardiorenal and mortality outcomes in type 2 diabetes

Eur J Clin Pharmacol. 2022 Apr;78(4):695-697. doi: 10.1007/s00228-021-03261-3. Epub 2021 Dec 3.
No abstract available

Keywords: Cardiorenal; Death; GLP-1 RAs; Network meta-analysis; SGLT2 inhibitors; Type 2 diabetes.

Publication types

  • Letter
  • Meta-Analysis

MeSH terms

  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptide-1 Receptor
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Network Meta-Analysis
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors
  • Glucagon-Like Peptide 1